Search results
AV Junction Ablation and Device Therapy in AF
Author(s):
Arnaud Bisson
,
Thibaut Lenormand
,
Mathieu Jacobs
,
et al
Added:
3 months ago
Review Article
BHRS Guidance on Device Implant and Follow-up
Author(s):
Paul Foley
,
Honey Thomas
,
Mark Dayer
,
et al
Added:
1 year ago
Expert Opinion
The Cowboy Bridge Technique for Lead Extraction
Author(s):
Elkin González Villegas
,
Panagiotis Mililis
,
Jesús Saldaña-García
,
et al
Added:
1 month ago
Case Report
Author(s):
Valentina Kutyifa
Added:
11 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of…
View more
Author(s):
Roberto Galea
Added:
1 year ago
EHRA 2025 - Three-year findings comparing the Amplatzer Amulet (St. Jude Medical-Abbott) and Watchman/FLX (Boston Scientific) systems for left atrial appendage (LAA) occlusion show a trend towards a lower ischemic risk in the Amulet group compared with the Watchman/FLX group in terms of a composite of CV death, stroke, transient ischemic attack or systemic embolism.Dr Roberto Galea (Inselspital,…
View more
Atrial High-rate Episodes: A Systematic Review and Meta-analysis
Author(s):
Hasaan Ahmed
,
Mahmoud Ismayl
,
Anirudh Palicherla
,
et al
Added:
1 year ago
Systematic Review
Added:
1 year ago
Source:
Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online…
View more
Blue Medical Devices
Supplier
Author(s):
Kent Nilsson
Added:
20 hours ago
EHRA 2026 — Dr Kent Nilsson (Piedmont Athens Regional Hospital, Athens, GA, USA) joins us to discuss 1-year outcomes from the ARRIVE study, evaluating the Abbott Aveir AR atrial leadless pacemaker against single-chamber atrial transvenous pacemakers in a real-world Medicare population.This prospective, observational coverage with evidence development (CED) study leverages real-world data from…
View more
Author(s):
Added:
19 hours ago
EHRA 2026, Paris — Dr Alexander Breitenstein (University Heart Center, Switzerland) joins us for a wide-ranging discussion on the evolving landscape of paediatric electrophysiology, exploring how advancing technologies, procedural refinements, and a growing evidence base are reshaping the long-term management of arrhythmias in children and young patients.Interview Questions:Can you introduce the…
View more